INTRACRANIAL MENINGIOMA
Clinical trials for INTRACRANIAL MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new INTRACRANIAL MENINGIOMA trials appear
Sign up with your email to follow new studies for INTRACRANIAL MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation after brain tumor surgery: helpful or harmful?
Disease control Recruiting nowThis study aims to determine whether adding radiation therapy after complete surgical removal of a specific type of brain tumor (grade 2 meningioma) helps prevent the tumor from coming back. About 163 adults who have had successful surgery will be randomly assigned to either rece…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New radiation drug trial offers hope for tough brain tumors
Disease control Recruiting nowThis study is testing whether a targeted radiation drug called [177Lu]Lu-DOTATATE can better control progressing brain meningioma tumors compared to standard treatments. About 153 adults whose tumors are growing will be randomly assigned to receive either the new drug or their do…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Personalized medicine attack on recurrent brain tumors
Disease control Recruiting nowThis study is testing four different targeted drugs for adults with meningioma brain tumors that are growing or have come back after treatment. The specific drug a patient receives is chosen based on the unique genetic mutations found in their tumor. The main goal is to see if th…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC